Itau Unibanco Holding S.A.’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $73.9K | Buy |
1,218
+41
| +3% | +$2.39K | ﹤0.01% | 214 |
|
|
2025
Q4 | $63.5K | Buy |
1,177
+425
| +57% | +$20.4K | ﹤0.01% | 215 |
|
|
2025
Q3 | $33.9K | Sell |
752
-3
| -0.4% | -$140 | ﹤0.01% | 292 |
|
|
2025
Q2 | $34.9K | Sell |
755
-9
| -1% | -$442 | ﹤0.01% | 299 |
|
|
2025
Q1 | $47K | Sell |
764
-8
| -1% | -$466 | ﹤0.01% | 270 |
|
|
2024
Q4 | $43.7K | Sell |
772
-310
| -29% | -$17.3K | ﹤0.01% | 259 |
|
|
2024
Q3 | $56K | Sell |
1,082
-327
| -23% | -$15.3K | ﹤0.01% | 187 |
|
|
2024
Q2 | $58.5K | Buy |
+1,409
| New | +$63K | ﹤0.01% | 176 |
|
|
2024
Q1 | – | Sell |
-2,388
| Closed | -$123K | – | 161 |
|
|
2023
Q4 | $123K | Buy |
2,388
+628
| +36% | +$33K | ﹤0.01% | 171 |
|
|
2023
Q3 | $102K | Sell |
1,760
-7
| -0.4% | -$429 | ﹤0.01% | 196 |
|
|
2023
Q2 | $113K | Buy |
1,767
+142
| +9% | +$9.52K | 0.01% | 221 |
|
|
2023
Q1 | $113K | Sell |
1,625
-2,939
| -64% | -$207K | 0.01% | 224 |
|
|
2022
Q4 | $329K | Sell |
4,564
-70,261
| -94% | -$5.3M | 0.01% | 172 |
|
|
2022
Q3 | $5.32M | Buy |
74,825
+70,285
| +1,548% | +$5.1M | 0.21% | 74 |
|
|
2022
Q2 | $350K | Buy |
4,540
+3,207
| +241% | +$244K | 0.01% | 178 |
|
|
2022
Q1 | $97K | Hold |
1,333
| – | – | ﹤0.01% | 270 |
|
|
2021
Q4 | $83K | Sell |
1,333
-975
| -42% | -$57.2K | ﹤0.01% | 235 |
|
|
2021
Q3 | $137K | Buy |
2,308
+335
| +17% | +$22.1K | 0.01% | 164 |
|
|
2021
Q2 | $132K | Buy |
+1,973
| New | +$129K | 0.01% | 132 |
|
|
2020
Q1 | – | Sell |
-5,055
| Closed | -$324K | – | 478 |
|
|
2019
Q4 | $324K | Sell |
5,055
-1,268
| -20% | -$72.6K | 0.02% | 141 |
|
|
2019
Q3 | $285K | Sell |
6,323
-14,804
| -70% | -$696K | 0.02% | 143 |
|
|
2019
Q2 | $957K | Buy |
21,127
+1,944
| +10% | +$90.6K | 0.05% | 106 |
|
|
2019
Q1 | $967K | Hold |
19,183
| – | – | 0.04% | 86 |
|
|
2018
Q4 | $967K | Buy |
19,183
+2,812
| +17% | +$151K | 0.04% | 86 |
|
|
2018
Q3 | $1.02M | Sell |
16,371
-3,469
| -17% | -$206K | 0.06% | 81 |
|
|
2018
Q2 | $1.1M | Buy |
19,840
+926
| +5% | +$50K | 0.12% | 58 |
|
|
2018
Q1 | $1.2M | Buy |
18,914
+9,551
| +102% | +$614K | 0.01% | 107 |
|
|
2017
Q4 | $573K | Buy |
9,363
+5,403
| +136% | +$338K | 0.03% | 152 |
|
|
2017
Q3 | $800K | Sell |
3,960
-7,034
| -64% | -$411K | 0.05% | 200 |
|
|
2017
Q2 | $613K | Buy |
10,994
+9,888
| +894% | +$538K | 0.07% | 93 |
|
|
2017
Q1 | $60K | Buy |
+1,106
| New | +$60.7K | 0.01% | 181 |
|
Other funds holding BMY
VCM
VPM
Itau Unibanco Holding S.A.'s BMY Position: Q1 2026 in Review
Itau Unibanco Holding S.A. increased its Bristol-Myers Squibb (BMY) stake by 3.5% in Q1 2026, buying an estimated $2.39K and bringing the position to 1,218 shares worth $73.9K. The position accounts for ﹤0.01% of the portfolio, ranked #214.
Itau Unibanco Holding S.A. first reported a position in BMY in Q1 2017 and has held it in 31 quarters since. The position peaked at $5.32M in Q3 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Itau Unibanco Holding S.A. held 1,218 shares of Bristol-Myers Squibb worth $73.9K as of Q1 2026.
- Itau Unibanco Holding S.A. bought 41 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.39K.
- Bristol-Myers Squibb made up ﹤0.01% of Itau Unibanco Holding S.A.'s portfolio in Q1 2026, its #214 holding.
- Itau Unibanco Holding S.A. first reported a position in Bristol-Myers Squibb in Q1 2017 and has held it in 31 quarters since.
- Itau Unibanco Holding S.A.'s Bristol-Myers Squibb position peaked at $5.32M in Q3 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2026, filed 14 May 2026.